Nanotherapeutics

Asia

FiercePharmaAsia—Samsung, Otsuka, China's foreign drug rule

Samsung won FDA nod for a Remicade biosim, Otsuka expanded anemia deal with Akebia, analysts are cautiously optimistic about China's foreign drug proposal.

Angus Liu Apr 28, 2017 9:01am